N. Vardakis

Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial

Vassilis Georgoulias, Charalambos Kouroussis, N. Androulakis et al. · Journal of Clinical Oncology · 1999 · 128 citations

Triplet Combination With Irinotecan Plus Oxaliplatin Plus Continuous-Infusion Fluorouracil and Leucovorin as First-Line Treatment in Metastatic Colorectal Cancer: A Multicenter Phase II Trial

John Souglakos, D. Mavroudis, Stylianos Kakolyris et al. · Journal of Clinical Oncology · 2002 · 119 citations

Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy

John Souglakos, A. Kalykaki, L. Vamvakas et al. · Annals of Oncology · 2006 · 63 citations

Oncology, Phase Ii Trial, Gastrointestinal Oncology +8

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

Zenia Saridaki, N. Androulakis, N. Vardakis et al. · British Journal of Cancer · 2012 · 56 citations · Full text

Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: A multicenter phase II study

N. Androulakis, Charalambos Kouroussis, S. Kakolyris et al. · Annals of Oncology · 1998 · 54 citations · Full text

Oncology, Non-small-cell Lung Cancer, Salvage Treatment +8